[Skip to content]
What your patients need to know before a hospital visit
Susan Calne explains the importance of preparing patients properly for a hospital visit.
Tolcapone is the only drug to be withdrawn and then re-instated. Kaye McIntosh reports.
David Burn summarises some of the key issues concerning depression in PD.
Infusions of levodopa are the only means of ensuring stable plasma concentrations of the drug. Dag Nyholm explains.
Mariella Graziano describes how physiotherapy acts as an adjunct to drug therapy.
How does the NSF for Long Term Conditions affect people with PD? Ian Philp discusses aspects of the document with Mary Fogarty.
Lucy Sutton describes the work of the National Council for Palliative Care in England, Wales and Northern Ireland.
Patients with PD who begin their treatment early after diagnosis with ropinirole only do better than those who commence with levodopa only.
People with PD who have young children now have the opportunity to mix with other families in a similar situation by going on a ‘Phoenix Days’ holiday.
Data presented at the 9th International Congress on Parkinson’s disease in Berlin showed that early treatment with the MAO-B inhibitor rasagiline has a positive effect on the functional impairments associated with Parkinson’s disease and that the effects of the drug are maintained for up to 6.5 years.
A study in the US of almost 150,000 people has suggested that the use of non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen is associated with a lower risk of Parkinson’s disease.
Pergolide appears to be associated with an increased risk of developing a problem with the aortic valve, the main outlet of the heart, according to a study conducted at the Mayo Clinic College of Medicine in Jacksonville.
Surgical removal of both ovaries can almost double a woman’s risk of developing PD or parkinsonism later on in life.